Category: Scientific and technical

For decades, the story of pharmaceutical innovation followed a familiar path.

The Protein Data Bank (PDB) now holds over 250,000 structures.

Why stronger collaboration is still one of the biggest untapped opportunities in drug discovery

Why the next phase of structural biology depends on dynamic data, better infrastructure and practical scientific use

Solving hidden scientific, biological and workflow challenges that generic software approaches consistently underestimate

As antibody therapeutics continue their rapid advance, structural biology is producing unprecedented volumes of data, from Cryo-EM, X-ray crystallography